Records 1 - 3
| BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysis.
Pathology, research and practice 2019 Sep 152671.
Min Kyueng-Whan, Choe Ji-Young, Kwon Mi Jung, Lee Hye Kyung, Kang Ho Suk, Nam Eun Sook, Cho Seong Jin, Park Hye-Rim, Min Soo Kee, Seo Jinwon, Kim Yun Joong, Kim Nan Young, Kim Ho You
| FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitor.
Pathology 2015 Oct 47 (6): 557-63.
Leslie Connull, Bowyer Samantha E, White Alison, Grieu-Iacopetta Fabienne, Trevenen Michelle, Iacopetta Barry, Amanuel Benhur, Millward Micha
| Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-a but Not Observation in Intermediate Risk Melanoma Patients.
PloS one 2015 10 (7): e0132745.
Tarhini Ahmad A, Lin Yan, Zahoor Haris, Shuai Yongli, Butterfield Lisa H, Ringquist Steven, Gogas Helen, Sander Cindy, Lee Sandra, Agarwala Sanjiv S, Kirwood John